Abayomi O K, Sadeghi-Nejad A
Int J Radiat Oncol Biol Phys. 1986 Jun;12(6):945-8. doi: 10.1016/0360-3016(86)90390-1.
A retrospective analysis of treatment in 20 patients who had received post-operative radiotherapy for medulloblastoma between 1969 and 1977 was completed. The patients were followed for a minimum of 60 months. Eleven patients survived for 5 or more years after treatment. The patients received 3600 cGy to the whole brain. The posterior fossa received 5600 cGY and the spinal axis 3600 cGY. Eight of eleven patients developed growth impairment; 6 of 7 patients had growth hormone deficiency. Since all endocrine gland failures are amenable to therapy, early attention to patients' growth rate and detection of hypothalamic-pituitary failure, would be of benefit to longterm survivors.
对1969年至1977年间接受髓母细胞瘤术后放疗的20例患者的治疗情况进行了回顾性分析。对这些患者进行了至少60个月的随访。11例患者在治疗后存活了5年或更长时间。患者全脑接受3600厘戈瑞的放疗剂量,后颅窝接受5600厘戈瑞,脊髓轴接受3600厘戈瑞。11例患者中有8例出现生长发育障碍;7例患者中有6例生长激素缺乏。由于所有内分泌腺功能衰竭都可进行治疗,因此早期关注患者的生长速度并检测下丘脑 - 垂体功能衰竭,将对长期存活者有益。